INFUSYSTEM HOLDINGS, INC Repayments of Long-Term Debt
INFUSYSTEM HOLDINGS, INC (INFU) reported Repayments of Long-Term Debt of $81.66 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2022-03-15
- INFUSYSTEM HOLDINGS, INC repayments of long-term debt for the quarter ending 2012-09-30 was $1.56M, a 27.57% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC repayments of long-term debt for the quarter ending 2011-12-31 was $1.23M, a 19.86% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC repayments of long-term debt for the quarter ending 2011-09-30 was $1.23M, a 19.26% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC repayments of long-term debt for the quarter ending 2010-12-31 was $1.03M.
- INFUSYSTEM HOLDINGS, INC repayments of long-term debt for fiscal 2021 was $81.66M, a 119.63% increase from fiscal 2020.
- INFUSYSTEM HOLDINGS, INC repayments of long-term debt for fiscal 2020 was $37.18M, a 663.76% increase from fiscal 2019.
- INFUSYSTEM HOLDINGS, INC repayments of long-term debt for fiscal 2019 was $4.87M.
- INFUSYSTEM HOLDINGS, INC repayments of long-term debt for fiscal 2011 was $4.52M, a 80.03% decline from fiscal 2010.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $81.66M 10-K · filed 2022-03-15 | |||
| 2020-12-31 | $37.18M 10-K · filed 2022-03-15 | |||
| 2019-12-31 | $4.87M 10-K · filed 2022-03-15 | |||
| 2012-09-30 | $1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $4.57M 10-Q · filed 2012-11-14 | ||
| 2012-06-30 | $3.01M 10-Q · filed 2012-08-08 | |||
| 2011-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | $2.46M derived: sum of 2 quarters · filed 2012-11-14 | $4.52M 10-K · filed 2012-03-16 | |
| 2011-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $3.29M 10-Q · filed 2012-11-14 | ||
| 2011-06-30 | $2.06M 10-Q · filed 2012-08-08 | |||
| 2010-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | $2.06M derived: sum of 2 quarters · filed 2012-03-16 | $22.62M 10-K · filed 2012-03-16 | |
| 2010-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $21.60M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $20.57M 10-Q · filed 2011-08-15 | |||
| 2009-12-31 | $8.56M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |